My name is Nazif, and I'm raising funds for my friend and colleague, Musa Yanık. Musa is a philosophy scholar in Türkiye who earned his PhD in 2025 after years of devoted work. Like many early-career academics, he hasn't yet been able to find a position, and that long uncertainty has taken a real toll. For about three years now, Musa has been living with chronic, treatment-resistant depression. Through all of it, he hasn't given up. He has worked closely with his doctors and tried a range of medications and therapies. Sadly, none have brought lasting relief. Depression that doesn't respond to standard treatment is one of the hardest forms to live with, and Musa has faced it with extraordinary patience.
Now, for the first time in a while, there's a genuine reason for hope. His doctors have recommended esketamine (brand name Spravato), an FDA-approved treatment developed specifically for people whose depression hasn't responded to other antidepressants. It's given as a nasal spray under medical supervision, and in clinical studies it has helped reduce depressive symptoms, sometimes within days, for patients who had run out of options. Musa's medical team is optimistic that this could be the turning point he has been waiting for.
There is one obstacle: cost. In Türkiye, esketamine isn't covered by the Ministry of Health, so Musa would have to pay for the full course himself. After years without stable income, that sum is simply out of reach. That's why I'm asking for your help. Every contribution, no matter the size, brings Musa one step closer to a treatment that could give him back his health and his future. If you can't donate, sharing this campaign means just as much. On behalf of Musa, thank you for your kindness and for believing his recovery is worth fighting for. Musa has also shared his own account of his situation on X, which you can read here: https://x.com/Musayanik_/status/2061861213022101766
Now, for the first time in a while, there's a genuine reason for hope. His doctors have recommended esketamine (brand name Spravato), an FDA-approved treatment developed specifically for people whose depression hasn't responded to other antidepressants. It's given as a nasal spray under medical supervision, and in clinical studies it has helped reduce depressive symptoms, sometimes within days, for patients who had run out of options. Musa's medical team is optimistic that this could be the turning point he has been waiting for.
There is one obstacle: cost. In Türkiye, esketamine isn't covered by the Ministry of Health, so Musa would have to pay for the full course himself. After years without stable income, that sum is simply out of reach. That's why I'm asking for your help. Every contribution, no matter the size, brings Musa one step closer to a treatment that could give him back his health and his future. If you can't donate, sharing this campaign means just as much. On behalf of Musa, thank you for your kindness and for believing his recovery is worth fighting for. Musa has also shared his own account of his situation on X, which you can read here: https://x.com/Musayanik_/status/2061861213022101766

